Reduced activity of the electron transport chain in liver mitochondria isolated from rats with secondary biliary cirrhosis

Hepatology ◽  
1992 ◽  
Vol 15 (6) ◽  
pp. 1160-1166 ◽  
Author(s):  
Stefan Krähenbühl ◽  
Jörg Stucki ◽  
Jürg Reichen
Hepatology ◽  
1994 ◽  
Vol 19 (2) ◽  
pp. 471-479 ◽  
Author(s):  
Stephan Krähenbühl ◽  
Christine Talos ◽  
Sven Fischer ◽  
Jürg Reichen

FEBS Letters ◽  
2016 ◽  
Vol 590 (23) ◽  
pp. 4318-4328 ◽  
Author(s):  
Ryan J. Mailloux ◽  
Adrian Young ◽  
Julia Chalker ◽  
Danielle Gardiner ◽  
Marisa O'Brien ◽  
...  

2006 ◽  
Vol 291 (5) ◽  
pp. H2067-H2074 ◽  
Author(s):  
Anastasia Andrukhiv ◽  
Alexandre D. Costa ◽  
Ian C. West ◽  
Keith D. Garlid

Opening the mitochondrial ATP-sensitive K+ channel (mitoKATP) increases levels of reactive oxygen species (ROS) in cardiomyocytes. This increase in ROS is necessary for cardioprotection against ischemia-reperfusion injury; however, the mechanism of mitoKATP-dependent stimulation of ROS production is unknown. We examined ROS production in suspensions of isolated rat heart and liver mitochondria, using fluorescent probes that are sensitive to hydrogen peroxide. When mitochondria were treated with the KATP channel openers diazoxide or cromakalim, their ROS production increased by 40–50%, and this effect was blocked by 5-hydroxydecanoate. ROS production exhibited a biphasic dependence on valinomycin concentration, with peak production occurring at valinomycin concentrations that catalyze about the same K+ influx as KATP channel openers. ROS production decreased with higher concentrations of valinomycin and with all concentrations of a classical protonophoretic uncoupler. Our studies show that the increase in ROS is due specifically to K+ influx into the matrix and is mediated by the attendant matrix alkalinization. Myxothiazol stimulated mitoKATP-dependent ROS production, whereas rotenone had no effect. This indicates that the superoxide originates in complex I (NADH:ubiquinone oxidoreductase) of the electron transport chain.


1985 ◽  
Vol 225 (1) ◽  
pp. 189-194 ◽  
Author(s):  
K N Dileepan ◽  
J Kennedy

1,1,1-Trifluoro-3-thenoylacetone was shown to cause complete inhibition of dihydroorotate oxidation in rat liver mitochondria as measured by orotate formation and the rate of dihydro-orotate-dependent reduction of 2,6-dichlorophenol-indophenol or cytochrome c. The inhibition by trifluorothenoylacetone was dose-dependent, and a concentration of 1 mM completely inhibited dihydro-orotate dehydrogenase activity. 1,10-Phenanthroline, another iron-chelating agent, also caused total inhibition of the liver enzyme. Whereas the iron chelators inhibited 100% of dihydro-orotate dehydrogenase activity in liver mitochondria, they inhibited only a maximum of 72% in the case of the brain enzyme. The inhibition by trifluorothenoylacetone was not prevented by addition of phenazine methosulphate or ubiquinone. Dihydro-orotate dehydrogenase-mediated generation of superoxide was abolished when the enzyme was fully inhibited by trifluorothenoylacetone or when the electron-transport system was blocked by antimycin A. These results suggest that the iron component(s) of dihydro-orotate dehydrogenase is of strategic importance for catalytic activity and transfer of reducing equivalents from the primary enzyme to the electron-transport chain. Furthermore, the study indicates that production of superoxide radicals during dihydro-orotate dehydrogenase-catalysed oxidation of dihydro-orotate may be at the cytochrome b-c1 segment of the electron-transport chain (as a consequence of autooxidation of ubisemiquinone) rather than at a site on the primary enzyme.


2015 ◽  
Vol 47 (4) ◽  
pp. 337-353 ◽  
Author(s):  
Omar Ortiz-Avila ◽  
Marco Alonso Gallegos-Corona ◽  
Luis Alberto Sánchez-Briones ◽  
Elizabeth Calderón-Cortés ◽  
Rocío Montoya-Pérez ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document